Literature DB >> 19139918

Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma.

You Wang1, Yuchan Wang, Chun Cheng, Yuhong Ji, Yueming Zhao, Lin Zou, Aiguo Shen.   

Abstract

PURPOSE: The aim of the present study was to examine whether Jab1 expression is correlated with p27 protein and its phosphorylation status as well as how it might be clinically relevant in epithelial ovarian carcinoma. Using ovarian carcinoma cell line HO-8910 to confirm and extend the findings.
METHODS: Immunohistochemical and Western blot analysis were done in 70 cases of epithelial ovarian cacinoma and HO-8910 cells.
RESULTS: Jab1 overexpression was detected in 84.3% (59 of 70) of malignant tumors and 31.6% (6 of 19) of benign tumors. A positive correlation between Jab1 and cytoplasmic p27 as well as Ser10 phosphorylated p27 was found in malignant ovarian tumors. In addition, patients displaying overexpression of Jab1, cytoplasmic p27 and Ser10 phosphorylated p27 were significantly associated with unfavorable clinicopathologic variables. Transfection with Jab1 in HO-8910 cells resulted in decreased p27 expression and this reduction was sensitive to 26S proteasome inhibitors. Overexpression of Jab1 caused p27 nuclear export and dissociate from Cdk2/Cyclin complex. What is more, increased expression of a phosphorylated histone H1 in the immune-complex obtained from Jab1 transfected HO-8910 cells was also observed.
CONCLUSIONS: Jab1, as a negative regulator of p27, may be associated with the progression and prognosis of epithelial ovarian tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139918     DOI: 10.1007/s00432-008-0531-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

Review 1.  Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.

Authors:  S V Ekholm; S I Reed
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

Review 2.  COP9 signalosome revisited: a novel mediator of protein degradation.

Authors:  C Schwechheimer; X W Deng
Journal:  Trends Cell Biol       Date:  2001-10       Impact factor: 20.808

3.  Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability.

Authors:  N Ishida; M Kitagawa; S Hatakeyama; K Nakayama
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

4.  Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.

Authors:  J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

5.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Authors:  K Tomoda; Y Kubota; J Kato
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

Review 6.  Regulation of the cdk inhibitor p27 and its deregulation in cancer.

Authors:  J Slingerland; M Pagano
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

7.  Mutations of phosphorylation sites Ser10 and Thr187 of p27Kip1 abolish cytoplasmic redistribution but do not abrogate G0/1 phase arrest in the HepG2 cell line.

Authors:  Xiaoxiang Guan; Longbang Chen; Jinghua Wang; Huaicheng Geng; Xiaoyuan Chu; Qun Zhang; Lili Du; Wei De
Journal:  Biochem Biophys Res Commun       Date:  2006-06-28       Impact factor: 3.575

8.  PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.

Authors:  Incheol Shin; F Michael Yakes; Federico Rojo; Nah-Young Shin; Andrei V Bakin; Jose Baselga; Carlos L Arteaga
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

9.  Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.

Authors:  Francisco J Esteva; Aysegul A Sahin; George Z Rassidakis; Linda X H Yuan; Terry L Smith; Ying Yang; Michael Z Gilcrease; Massimo Cristofanilli; Rita Nahta; Lajos Pusztai; François-Xavier Claret
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

10.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  5 in total

1.  Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27.

Authors:  Ling Gao; Shuo Huang; Wenhao Ren; Lu Zhao; Jingwei Li; Keqian Zhi; Yincheng Zhang; Hong Qi; Chen Huang
Journal:  Med Oncol       Date:  2012-02-04       Impact factor: 3.064

2.  JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis.

Authors:  You Wang; Ya-Nan Yu; Shu Song; Tie-Jun Li; Jing-Ying Xiang; Hong Zhang; Mu-Dan Lu; Fang Ji; Ling-Qing Hu
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-27       Impact factor: 4.553

3.  Cyclin-dependent kinase inhibitors, p16 and p27, demonstrate different expression patterns in thymoma and thymic carcinoma.

Authors:  Mutsuko Omatsu; Toshiaki Kunimura; Tetsuya Mikogami; Akira Shiokawa; Atsuko Masunaga; Tomoko Nagai; Akihiko Kitami; Takashi Suzuki; Mitsutaka Kadokura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-18

4.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

5.  p27 Is a critical prognostic biomarker in non-alcoholic steatohepatitis-related hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Yuki Hirose; Mami Osawa; Shun Fujimaki; Masayuki Kubota
Journal:  Int J Mol Sci       Date:  2013-11-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.